Trials / Completed
CompletedNCT02010931
Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients
A Retrospective Analysis of Hematological Relapse Free Survival and Overall Survival in Adult Patients With Philadelphia-Negative B-Precursor Acute Lymphoblastic Leukemia in Complete Hematological Remission With Minimal Residual Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 310 (actual)
- Sponsor
- Amgen · Industry
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
A retrospective analysis of historical data looking at relapse free survival and overall survival rates in adult philadelphia negative B-pre-cursor acute lymphoblastic leukemia patients.
Detailed description
A retrospective observational study reviewing historical survival data (relapse free survival and overall survival) for adult patients who have philadelphia negative B-precursor acute lymphoblastic leukemia, and are in complete hematological remission with minimal residual disease.
Conditions
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2014-03-01
- Completion
- 2014-06-01
- First posted
- 2013-12-13
- Last updated
- 2022-09-15
Locations
10 sites across 8 countries: Czechia, France, Germany, Italy, Poland, Russia, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT02010931. Inclusion in this directory is not an endorsement.